NPI registry status
Active
2026 NPPES data Ambulatory Care Pharmacist NPI 1154867513 PHARM.D.
Verify on CMS → Natasha Hermis, PHARM.D.
Ambulatory Care Pharmacist in Modesto, California.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 3,496 in Ambulatory Care Pharmacist, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
81
Medicare Part D claims · 77 beneficiaries · Ambulatory Care Pharmacist avg: 492
Generic prescribing
0%
generic claims · 100% brand-name · higher generic rates reduce patient out-of-pocket costs
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Natasha Hermis, PHARM.D. filed 81 Medicare Part D claims in 2023 as a Ambulatory Care Pharmacist in Modesto, California, prescribing 0% generic.
- 81
- Part D claims, 2023
- 0%
- generic prescribing
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Natasha Hermis, PHARM.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023, across all CMS prescribers nationally
81 0th percentile higher than 0% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
What does the federal data show about Natasha Hermis, PHARM.D.?
Quality data not reportedPrimary specialty
Ambulatory Care Pharmacist
Medicare Part D claims
81 84% vs specialty avg
Specialty distribution in California
How Ambulatory Care Pharmacist compares to other specialties among California providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Ambulatory Care Pharmacist. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Natasha Hermis, PHARM.D. appears in the CMS NPPES registry as an Ambulatory Care Pharmacist provider holding PHARM.D. credentials at 3500 COFFEE RD, Modesto, CA, 95355, with a listed phone of (209) 341-0814. NPI 1154867513 was issued on 01/10/2017.
Medicare Part D records for calendar year 2023 show 81 prescription claims written by this provider, covering 77 Medicare beneficiaries and totaling roughly $22K in drug spend, split 100% brand-name and 0% generic by claim count.
Ambulatory Care Pharmacist is a narrow specialty nationwide, with 3,496 enrolled providers across 52 states and an average of 492 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1154867513 |
|---|---|
| Specialty | Ambulatory Care Pharmacist |
| Credentials | PHARM.D. |
| Gender | Female |
| NPI Issued | 01/10/2017 |
License & disciplinary context - California MBC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 - they are NOT specific to Natasha Hermis, PHARM.D.. To verify Natasha Hermis, PHARM.D.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases
MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Brand-heavy
Natasha Hermis, PHARM.D. - brand share 100.0%
Ambulatory Care Pharmacist average
100% brand-name claims vs 0% generic, on 81 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
81
Total Claims
$22K
Total Drug Cost
77
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 81
- Total Day Supply
- 81
- Brand vs Generic
- 100% brand / 0% generic
- Brand Drug Cost
- $22K
- Generic Drug Cost
- $0
Patient Demographics
- Average Patient Age
- 74.7 years
- Avg HCC Risk Score
- 1.36
- Gender Split
- 56% female / 44% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
| Drug | Claims |
|---|---|
| Shingrix Varicella-Zoster Ge/As01b/Pf | 23 |
| Abrysvo "Rsv Vacc | N/A |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Ambulatory Care Pharmacist Overview
How Natasha Hermis, PHARM.D. fits within the Ambulatory Care Pharmacist landscape nationally.
3,496
Ambulatory Care Pharmacist Providers in US
52
States with Ambulatory Care Pharmacist
492
Avg Claims per Provider
Natasha Hermis, PHARM.D.'s 81 claims are below the specialty average of 492.
Nearby Ambulatory Care Pharmacist Providers in California
Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as Hermis.
Clare Adams
Mission Viejo, CA
Kristine Adzhemyan
Los Angeles, CA
Dr. Omar Ahmed
PHARMD
San Rafael, CA
Dr. Soo Ahn
PHARM.D.
Simi Valley, CA
Dr. Genevieve Aichelman
PHARM.D.
Lemoore, CA
Compare Ambulatory Care Pharmacist nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the California medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Ambulatory Care Pharmacist peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore California
Frequently Asked Questions
What is Natasha Hermis, PHARM.D.'s specialty? ▼
Natasha Hermis, PHARM.D. specializes in Ambulatory Care Pharmacist and practices in Modesto, California. Credentials: PHARM.D..
How much does Natasha Hermis, PHARM.D. prescribe under Medicare Part D? ▼
In 2023, Natasha Hermis, PHARM.D. wrote 81 Medicare Part D claims totaling $22K in drug costs for 77 beneficiaries.
Where is Natasha Hermis, PHARM.D. located? ▼
Natasha Hermis, PHARM.D. is located at 3500 COFFEE RD, Modesto, CA, 95355. Phone: (209) 341-0814.
What is Natasha Hermis, PHARM.D.'s NPI number? ▼
Natasha Hermis, PHARM.D.'s National Provider Identifier (NPI) is 1154867513, issued on 01/10/2017.
Does Natasha Hermis, PHARM.D. prescribe more brand-name or generic drugs? ▼
Natasha Hermis, PHARM.D.'s prescribing is 100% brand-name and 0% generic drugs by claim count, with $22K in brand drug costs.
How many Ambulatory Care Pharmacist providers are there in the US? ▼
There are 3,496 Ambulatory Care Pharmacist providers across 52 states in the US. The average Ambulatory Care Pharmacist provider writes 492 Medicare Part D claims per year.
What drugs does Natasha Hermis, PHARM.D. prescribe most often? ▼
Based on 2023 Medicare Part D data, Natasha Hermis, PHARM.D.'s most frequently prescribed drugs include Shingrix, Abrysvo. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Natasha Hermis, PHARM.D. accept Medicare? ▼
Natasha Hermis, PHARM.D. appears in CMS Medicare data with 81 Part D claims and 77 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Natasha Hermis, PHARM.D.'s credentials? ▼
Natasha Hermis, PHARM.D.'s NPI is 1154867513 with credentials PHARM.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.